申请人:Baettig Urs
公开号:US20100029670A1
公开(公告)日:2010-02-04
The present invention relates to compounds of formula (I)
wherein X, R
1
, R
2
, R
3
, R
4
and R
5
are as defined herein, which are useful for treating diseases which respond to CXCR2 receptor mediators. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
本发明涉及以下式(I)的化合物
其中X,R1,R2,R3,R4和R5如本文所定义,这些化合物对于治疗对CXCR2受体介质有响应的疾病是有用的。还描述了含有这些化合物的药物组合物以及制备这些化合物的方法。